Iovance faces major setbacks with AMTAGVI's weak launch, cash burn, and scalability issues despite scientific progress. Find ...

T cells are a promising cancer therapy that are made from the patient's own T cells, which are reprogrammed to fight their ...

Chimeric antigen receptor (CAR)-T cells are a promising cancer therapy that are made from the patient's own T cells, which ...

In modern immunotherapy, modified immune cells are introduced into the body to attack tumors and other targets. Researchers ...

Panelists discuss how autologous stem cell transplant remains essential in frontline multiple myeloma management despite improved quadruple therapy outcomes, emphasizing that current evidence still ...

Def Leppard's Vivian Campbell is "completely clean" of cancer. The 62-year-old rocker was diagnosed with Hodgkin's lymphoma ...

Novel combination of acimtamig and an allogenic natural killer cell product shows safety and promising objective response ...

In developing this automated cell therapy processing platform, Limula’s founders aim to create a disruptive production ...

CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next ...

Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary ...